financetom
Business
financetom
/
Business
/
NVIDIA, Micron, SMCI Stocks Are Down Monday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NVIDIA, Micron, SMCI Stocks Are Down Monday: What's Going On?
Sep 16, 2024 10:10 AM

Shares of NVIDIA Corp. ( NVDA ) , Super Micro Computer, Inc. ( SMCI ) and Micron Technology, Inc. ( MU ) shares are trading lower Monday. Here's a look at what's moving the stocks. 

What To Know:

The intense growth of early-2024 in the semiconductor sector has slowed recently amid speculation surrounding a possible AI "bubble" as investors grow impatient for returns on the massive capital expenditures involved with AI-infrastructure build-out.  

Micron’s stock has shed more than $70 billion in market value since June, and Raymond James recently lowered its price target on the stock from $160 to $125. Investors will be watching when the company reports its fourth-quarter financial results after the market close on Sept. 25. 

Read Next: Why Temu Parent PDD Holdings’ Stock Is Down

The market has also digested a recent short report on SMCI, coupled with the company's delayed 10-K filing, and investors were less-than-impressed with Nvidia's ( NVDA ) second-quarter results. 

However, Nvidia ( NVDA ) shares rose last week after CEO Jensen Huang said the company is experiencing "great demand" for its Blackwell chips causing frustration among some of its customers. Huang also addressed concerns related to the rising geopolitical tensions surrounding key Nvidia ( NVDA )-supplier, Taiwan Semiconductor Manufacturing Company Ltd. ( TSM ) .

In addition to rising tensions between China and Taiwan, chipmakers face increasing restrictions and scrutiny on exports to China and its allies which may be dragging on the sector as well. 

NVDA, SMCI, MU Price Action: According to Benzinga Pro, Nvidia ( NVDA ) shares are down 2.64% at $116.96, SMCI shares are down 1.17% at $451.81 and Micron shares are down 5.03% at $86.62 at the time of publication Monday.

Read Also:

Oracle Stock Climbs On $104 Billion FY29 Revenue Forecast: What To Know

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BP Q1 Underlying Earnings, Revenue Drop
BP Q1 Underlying Earnings, Revenue Drop
May 25, 2025
06:04 AM EDT, 04/29/2025 (MT Newswires) -- BP (BP) reported Q1 underlying replacement cost profit Tuesday of $0.53 per diluted American depositary share, down from $0.97 a year earlier. Sales and other operating revenue for the quarter ended March 31 were $46.91 billion, down from $48.80 billion a year earlier. Analysts polled by FactSet IQ expected $45.49 billion. BP shares...
Spotify forecasts second-quarter profit below estimates, shares fall
Spotify forecasts second-quarter profit below estimates, shares fall
May 25, 2025
(Reuters) - Spotify ( SPOT ) forecast current-quarter operating profit below Wall Street estimates on Tuesday as it grapples with higher payroll taxes, taking the shine off its strong subscriber growth and sending the company's shares down 8% before the bell. The company's efforts to boost profitability are being closely watched by investors after it benefited in recent years from...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
US FDA approves Abeona's skin disorder therapy
US FDA approves Abeona's skin disorder therapy
May 25, 2025
April 29 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Abeona Therapeutics' ( ABEO ) gene therapy for a rare skin disorder. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved